Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
08/2005
08/24/2005CN1216061C Ascorbic acid 2-phosphate metal salt with low calcium content
08/24/2005CN1216060C Phosphonate ester nucleotide compound
08/24/2005CN1216059C Phosphonio, salt and its prepn and use as well as phosphine for preparing the phosphonio salt and its prepn
08/24/2005CN1216050C 5,6,7-trinor -4,8-inter-m-phenylene PGI2 derivative and drugs containing the same
08/24/2005CN1216030C O-acyl-alpha-hydroxycarboxylic ester compounds and their preparation method
08/24/2005CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
08/24/2005CN1215795C Method for continuously extracting egg yolk oil and egg yolk lecithin by using supercritical CO2 extraction process
08/23/2005US6933394 Catalyst for synthesizing alkylene carbonate
08/23/2005CA2109161C Substituted 1-h-3-aryl-pyrrolidine-2,4-dione derivatives
08/18/2005WO2005075488A1 Method for producing sodium fosphenytoin
08/18/2005WO2005075487A1 Crystalline form of risedronate monosodium
08/18/2005WO2005075486A1 Method of synthesizing compounds having a phosphorus-fluorine-18 bond
08/18/2005WO2005075074A1 Inorganic solids, such as porous and particularly mesoporous inorganic solids, which are modified by transition metal-chelating organic molecules, preparation method thereof and use of same as catalysts
08/18/2005WO2005058888A3 Oxazolidinone-quinolone hybrid antibiotics
08/18/2005US20050182265 Photoaffinity-labeled sphingomyelin analogs and processes thereof
08/18/2005US20050182148 Photosensitive adhesive composition
08/18/2005US20050182139 Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof
08/18/2005US20050182112 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus
08/18/2005US20050182031 Florfenicol prodrug having improved water solubility
08/18/2005US20050182027 radiolabeled phosphonium or ammonium salts that accumulate in mitochondria of cancer cells; cancer diagnosis; tomography; distinguishes between tissue inflammation and tumors; e.g. F18-3-fluoropropyltriphenyl phosphonium bromide
08/18/2005US20050182019 Phosphonate compounds
08/18/2005US20050181469 Beta-lactamase substrates having phenolic ethers
08/18/2005US20050181393 Novel chelating agents and highly luminescent and stable chelates and their use
08/18/2005DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease
08/18/2005CA2555305A1 Method of synthesizing compounds having a phosphorus-fluorine-18 bond
08/17/2005EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses
08/17/2005EP1563559A2 An innovative method for the preparation of proton conducting nanopolymeric membranes for use in fuel cells or in catalytic membrane reactors
08/17/2005EP1562963A1 Novel lipophilic compounds and uses thereof
08/17/2005EP1562909A1 Ophthalmic compositions for treating ocular hypertension
08/17/2005EP1562609A1 Inositolized phospholipids
08/17/2005EP1496889B1 Stabilized ascorbic acid derivatives
08/17/2005EP1282639B1 Polyamide nucleic acid derivatives, agents and methods for producing the same
08/17/2005CN1656854A Electroluminescent iridium compounds with phosphinoalkoxides and phenylpyridines or phenylpyrimidines and devices made with such compounds
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
08/17/2005CN1656108A Fluorinated phosphonic acids
08/17/2005CN1656107A Plasma carboxypeptidase B inhibitors
08/17/2005CN1656104A Shaped bodies containing metal-organic frameworks
08/17/2005CN1656089A Phenyl-thiophene type vitamin D receptor modulators
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1654514A Multilayer acrylate film with improved optical and mechanical properties
08/17/2005CN1215076C Heteroaromatic inhibitors of fructose 1, 6-bisphosphatase
08/17/2005CN1215075C Process for prodn. of phosphor organiccompounds
08/17/2005CN1215074C New technique for synthesizing dialkyl ester phosphorous acid
08/17/2005CN1215073C Fungicides
08/17/2005CN1215030C 1, 4-diaryl-2-fluoro-2-butene insecticidal and acaricidal agents
08/16/2005US6930189 Chiral ligand
08/16/2005US6930100 Phosphate prodrugs of fluoroxindoles
08/16/2005CA2399974C Process for making geminal bisphosphonates
08/11/2005WO2005073241A1 Separation of nickel(0) complexes and phosphorus-containing ligands from nitrile mixtures
08/11/2005WO2005073229A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/11/2005WO2005073214A2 Novel inhibitors of chymase
08/11/2005WO2005072746A1 P2x receptor inhibitor
08/11/2005WO2005072531A1 Use of certain phospholipids to deliver hormonal effects to plants
08/11/2005WO2005072477A2 Method for the separation of phospholipids from phospholipid-containing materials
08/11/2005WO2005051298A3 Novel phosphorus-containing thyromimetics
08/11/2005WO2005039504A3 Compounds and methods for treating toll-like receptor 2-related diseases and conditions
08/11/2005WO2005007635A3 Combretastatin derivatives with cytotoxic action
08/11/2005US20050176990 Catalysis with transition metal and nitrogen on a carbon support, producing N-(phosphonomethyl)glycine
08/11/2005US20050176989 Oxidation of N-(phosphonomethyl)iminodiacetic acid with an oxidizing agent and a catalyst of a carbon support having nitrogen and carbon
08/11/2005US20050176983 Providing solvent, adding reactant such as 6H-dibenzo[c,e] [1,2]oxaphosphorin 6-oxide, adding an ortho ester and adding alcohol
08/11/2005US20050176982 Salt formation; combining an alkyl, aryl or cyclohexyl iodonium salt derivative containing a halide anion or a carboxylate anion with a sulfonic acid ester, dialkylsuric acid or a phosphoric acid derivative; sulfonate, phospate or sulfate anion with an iodoinium or sulfonium alkyl cation
08/11/2005US20050176978 Immobilized iminophosphatranes useful for transesterification
08/11/2005US20050176948 Libraries; locked nucleic acids; peptide nucleic acids
08/11/2005US20050176860 Featureless x-ray diffraction pattern; 59 to 63 degree celsius melting range; prepared by melting and rapid cooling resolidification; polyolefin oxidation, heat and light stabilizer
08/11/2005US20050176769 Novel inhibitors of chymase
08/11/2005US20050176697 crystal of 3-[4-(1-methyl-4-pyridinio)-2-thiazolylthio]-7 beta -[2-(5-phosphonoamino-1,2,4-thiadiazol-3-yl)-2(Z)-ethoxyiminoacetamido]-3-cephem-4-carboxylate with acetic acid and water, crystals; anti-Methicillin Resistant Staphylococcus aureus agent; storage stability, high purity
08/11/2005US20050176688 Halocombstatins and methods of synthesis thereof
08/11/2005US20050176684 5-(4-Bromo-3-aminophenyl)-2-furanphosphonic acid; fructose-1,6-biphosphatase inhibitor; diabetes type 1 and 2, glycogen storage diseases, cardiovascular diseases with increased insulin levels, atherosclerosis; in vitro, in vivo;
08/11/2005US20050176673 guanin-9-yl, adenin-9-yl, 2,6-diaminopurin-9-yl, 2-aminopurin-9-yl or their 1-deaza, 3-deaza, or 8-aza compounds, or cytosin-1-yl - ethoxymethanephosphonic acid derivatives, used to treat osteoporosis and other disorders of bone metabolism, cancer, or viral infections
08/11/2005US20050176065 Biarsenical molecules label tetracycsteine polypeptides; orthogonal labelling for observing conformational changes; solid phase synthesis; kits
08/11/2005US20050175534 Method of synthesizing compounds having a phosphorus-fluorine-18 bond
08/11/2005DE102004032781A1 New lipid-modified bis-phosphonic acid derivatives, useful e.g. for transporting therapeutic or diagnostic agents, with affinity for bone, also as corrosion inhibitors
08/11/2005CA2554749A1 P2x receptor inhibitor
08/11/2005CA2554522A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/11/2005CA2554205A1 Novel inhibitors of chymase
08/11/2005CA2553778A1 Separation of nickel(0) complexes and phosphorus-containing ligands from nitrile mixtures
08/11/2005CA2553671A1 Method for the separation of phospholipids from phospholipid-containing materials
08/10/2005EP1560817A1 Methods and compositions of novel triazine compounds
08/10/2005EP1560648A1 Use of tellurium in carbon-supported, noble metal-containing catalysts for liquid phase oxidation reactions
08/10/2005EP1560602A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof
08/10/2005EP1395265A4 Combretastatin a-3 prodrug
08/10/2005EP1379473A4 Corrosion inhibitors for aqueous systems
08/10/2005EP1009447B1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
08/10/2005CN1653082A Platinum complexes having antitumor activity
08/10/2005CN1653074A Compound and processes for the preparation and use thereof
08/10/2005CN1653064A Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
08/10/2005CN1653033A Method of purifying quaternary alkylammonium salt and quaternary alkylammonium salt
08/10/2005CN1653023A Method for producing C13-alcohol mixtures
08/10/2005CN1652769A Phosphate prodrugs of fluorooxindoles
08/10/2005CN1651443A Monophosphine ligand having C2 symmetric skeleton, synthesis method and application
08/10/2005CN1651442A Synthesis method of oxaphosphine phenanthrine fire retardant intermediate-2-(2'hydroxy phenyl) phosphenylic acid
08/10/2005CN1651441A Preparation of an alkenylphosphonic acid derivative
08/10/2005CN1214037C Removal of chloride from phosphonomethyliminodiacetic acid process
08/10/2005CN1213999C Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
08/10/2005CN1213807C Hydroformylation of unsaturated compounds using polymeric phosphite ligands
08/09/2005US6927304 De-oxygenation treatment for noble metal on carbon catalysts used in liquid phase oxidation reactions
08/09/2005US6927290 Production of mixed acid anhydride and amide compound
08/09/2005US6927262 catalysts for polymerizing olefins
08/09/2005US6927212 Design and synthesis of renal dipeptidase inhibitors
08/09/2005US6927036 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 554